News | AP VALVES & SH 2021 Virtual

Upfront Protection Needed for 'Rare But Real' Risk of TAVR-related Coronary Artery Occlusion

[AP VALVES & SH 2021] Expert highlights when and how to protect at-risk arteries for TAVR patients

News | AP VALVES & SH 2021 Virtual

Evolut or Sapien? Expert Unravels 'Equation' for Choosing TAVR Device

[AP VALVES & SH 2021] BEV/SEV experience, proper technique, detailed patient assessment highlighted as critical factors for optimal TAVR outcomes

News | SummitMD

FLOWER-MI: FFR Shows No Benefit over Angio for Complete Revasc in Multi-vessel STEMIs

Findings say FFR-guided PCI not superior (or cost-effective) compared to angio-guided PCI, although experts warn results may not be conclusive

News | SummitMD

'Next-Gen' ADAPTABLE Study Says Low-Dose Aspirin Equal to High-Dose for ASCVD Patients

High-tech, low-cost study reflects real-world data and finds 81mg aspirin superior, although critics say high switching rate impacts reliability of findings

News | SummitMD

In DES-PCI Era, Clopidogrel Gains Traction over Aspirin as Maintenance Monotherapy after DAPT

HOST-EXAM reports post-DAPT clopidogrel monotherapy drops ischemic and bleeding events by 30% in Korean population

News | SummitMD

Asan Medical Center First in Asia to Complete 1,000 TAVI Cases

AMC Heart Team records 96% success rate with 1% mortality, complications rate for high-risk elderly patients

News | TCTAP 2021 Virtual

Future Journey of Transcatheter Mitral Valve Interventions

April 24th Hot Topics Session of TCTAP 2021 Virtual